The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
Currently there are no vaccines approved anywhere in the world for gonorrhoea, and antimicrobial resistance to existing treatments is increasing
Supply readiness follows months of manufacturing to ensure timely and ample supply
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Sajjan India Limited is looking for expansion, both organically and through acquisitions, to achieve the planned growth
Approximately 60 to 78% of individuals diagnosed with Asthma also have concurrent Allergic Rhinitis
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
Subscribe To Our Newsletter & Stay Updated
